Disease | hepatitis c |
Phenotype | C0034150|purpura |
Sentences | 3 |
PubMedID- 24621321 | The ifn-α treatment is considered an immune-modulator and increases the risk for immune thrombocytopenia purpura in patients with hepatitis c [10], but the mechanism of ifn-induced autoimmune thrombocytopenia is unclear [10]. |
PubMedID- 23888238 | Thrombotic thrombocytopenic purpura in a patient with interferon treated hepatitis c successfully treated with rituximab. |
PubMedID- 25209590 | However, clinical use of eltrombopag later confirmed that it is a safe and effective drug for immune thrombocytopenic purpura or thrombocytopenia associated with hepatitis c virus infection. |
Page: 1